FOUND: Vbl - What They Never Told You

Varun Beverages Ltd. has extended its exclusive bottling and trademark license agreement with PepsiCo Inc. in India until April 30, 2049, replacing the previous term ending in 2039. The revised agreement also removes a key restriction, allowing VBL to pursue businesses outside of PepsiCo operations, signaling a deepening strategic partnership.

VBL Therapeutics (NASDAQ: VBLT) received Fast Track designation from the U.S. Food and Drug Administration (FDA) for its drug candidate Ofra-Vec (VB-111) in combination with Paclitaxel for the treatment of patients with platinum-resistant ovarian cancer.